GE Healthcare Expects 2024 Adjusted EPS Guidance Of $4.25-$4.35 Compared To Prior Guidance Of $4.20-$4.35 Versus Consensus Of $4.25
Portfolio Pulse from Benzinga Newsdesk
GE Healthcare has updated its 2024 financial guidance, expecting adjusted EPS of $4.25-$4.35, slightly up from prior guidance. Organic revenue growth is expected at the lower end of 1%-2% due to China market softness. Adjusted EBIT margin is projected to expand to 15.8%-16.0%, with free cash flow around $1.8 billion.
October 30, 2024 | 10:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GE Healthcare has slightly raised its 2024 adjusted EPS guidance to $4.25-$4.35, with organic revenue growth expected at the lower end of 1%-2% due to China market softness. The adjusted EBIT margin is projected to expand to 15.8%-16.0%, and free cash flow is anticipated to be approximately $1.8 billion.
The slight increase in EPS guidance and EBIT margin expansion are positive indicators for GE Healthcare's financial performance. However, the lower end revenue growth due to China market softness may temper investor enthusiasm. Overall, the guidance suggests a stable outlook with potential for modest stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100